Early Access — free while we kick the tires
EdgarHawk

Miller-Rich Nancy

Director

Director
1 filing analyzed · 1 company · Latest 2024-10-21

Companies

Company Buys Sells Direction
Aldeyra Therapeutics, Inc. ALDX 2 0 Net buying

Activity

October 2024
low
Buy
922 shares
$10,447
Significance 4/10

Director Nancy Miller-Rich purchased 922 shares in 2 transactions totaling $10,446.70; stock down 12.5% from 52-week high at $5.53

Nancy Miller-Rich, as a Director, made 2 separate purchases totaling 922 shares for $10,446.70 over a two-year span (May 2021 at $12.81 and April 2023 at $10.13), establishing an initial position from zero shares. The company is unprofitable with net income of $-16,847,572.00, and the stock currently trades at $5.53—below both transaction prices and 12.5% below its 52-week high of $6.32. The time gap between purchases (nearly two years) and the subsequent price decline to below the blended average price of $11.33 provide limited immediate signal about insider conviction at entry or near-term pricing foresight. Investors should note the unprofitable status of the underlying business alongside the modest absolute purchase volume.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access